Q-VD-OPh hydrate
To Order Contact us: stephen@expresspharmapulse.com
Q-VD-OPh |
|||
| 1170-5 | Biovision | EUR 874.8 | |
Q-VD-OPh |
|||
| 1170-50 | Biovision | Ask for price | |
Q-VD-OPh |
|||
| HY-12305 | MedChemExpress | 10mM/1mL | EUR 228 |
EZSolution? Q-VD-OPh |
|||
| 1173-1 | Biovision | EUR 248.4 | |
Q-VD(OMe)-OPh |
|||
| A8165-1 | ApexBio | 1 mg | EUR 212.4 |
|
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor, provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors. |
|||
Q-VD(OMe)-OPh |
|||
| A8165-10 | ApexBio | 10 mg | EUR 756 |
|
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor, provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors. |
|||
Q-VD(OMe)-OPh |
|||
| A8165-25 | ApexBio | 25 mg | EUR 1173.6 |
|
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor, provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors. |
|||
Q-VD(OMe)-OPh |
|||
| A8165-5 | ApexBio | 5 mg | EUR 477.6 |
|
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor, provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors. |
|||
Q-VD(OMe)-OPh |
|||
| A8165-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 853.2 |
|
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor, provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors. |
|||
Q-VD(OMe)-OPh |
|||
| A8165-S | ApexBio | Evaluation Sample | EUR 97.2 |
|
Description: Q-VD-OPh (quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone) is a broad spectrum caspase inhibitor, provides a cost effective, non toxic, and highly specific means of apoptotic inhibition and provides new insight into the design of new inhibitors. |
|||
(R)-Q-VD-OPh |
|||
| HY-12305A | MedChemExpress | 10mg | EUR 308.4 |
EZSolution? Q-VD-OPh, Negative Control |
|||
| 1174-1 | Biovision | EUR 248.4 | |
Pan-caspase inhibitor, Q-VD(OMe)-OPh |
|||
| 2787-1 | Biovision | EUR 314.4 | |
Pan-caspase inhibitor, Q-VD(OMe)-OPh |
|||
| 2787-5 | Biovision | EUR 966 | |
Q-VE-Oph |
|||
| GL5302-1MG | Glentham Life Sciences | 1 mg | EUR 302.4 |
EZSolution? Q-DEVD-OPh |
|||
| 1178-1 | Biovision | EUR 326.4 | |
Caspase-3 Inhibitor Q-DEVD-OPh |
|||
| 1175-1 | Biovision | EUR 326.4 | |
Caspase-3 Inhibitor Q-DEVD-OPh |
|||
| 1175-3 | Biovision | EUR 639.6 | |
Caspase-3 Inhibitor Q-DEVD-OPh |
|||
| 1175-5 | Biovision | EUR 966 | |
Caspase-8 Inhibitor, Q-IETD-OPh |
|||
| 1176-1 | Biovision | EUR 366 | |
Caspase-8 Inhibitor, Q-IETD-OPh |
|||
| 1176-3 | Biovision | EUR 823.2 | |
Caspase-8 Inhibitor, Q-IETD-OPh |
|||
| 1176-5 | Biovision | EUR 1188 | |
Caspase-9 Inhibitor, Q-LEHD-OPh |
|||
| 1177-1 | Biovision | EUR 352.8 | |
Caspase-9 Inhibitor, Q-LEHD-OPh |
|||
| 1177-3 | Biovision | EUR 810 | |
Caspase-9 Inhibitor, Q-LEHD-OPh |
|||
| 1177-5 | Biovision | EUR 1161.6 | |
VD/ Rat VD ELISA Kit |
|||
| ELA-E0917r | Lifescience Market | 96 Tests | EUR 1063.2 |
QVD-OPh Negative Control |
|||
| 1171-1 | Biovision | EUR 248.4 | |
QVD-OPh Negative Control |
|||
| 1171-3 | Biovision | EUR 483.6 | |
QVD-OPh Negative Control |
|||
| 1171-5 | Biovision | EUR 705.6 | |
VD-PEG-NH2,2K |
|||
| 33-HE090005-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Porcine VD ELISA Kit |
|||
| EPV0030 | Abclonal | 96Tests | EUR 625.2 |
Porcine VD ELISA Kit |
|||
| EPV0033 | Abclonal | 96Tests | EUR 625.2 |
Rabbit VD ELISA Kit |
|||
| ERTV0030 | Abclonal | 96Tests | EUR 625.2 |
Rabbit VD ELISA Kit |
|||
| ERTV0033 | Abclonal | 96Tests | EUR 625.2 |
Rat VD ELISA Kit |
|||
| ERV0030 | Abclonal | 96Tests | EUR 625.2 |
Rat VD ELISA Kit |
|||
| ERV0033 | Abclonal | 96Tests | EUR 625.2 |
Goat VD ELISA Kit |
|||
| EGTV0030 | Abclonal | 96Tests | EUR 625.2 |
Goat VD ELISA Kit |
|||
| EGTV0033 | Abclonal | 96Tests | EUR 625.2 |
Human VD ELISA Kit |
|||
| EHV0030 | Abclonal | 96Tests | EUR 625.2 |
Human VD ELISA Kit |
|||
| EHV0033 | Abclonal | 96Tests | EUR 625.2 |
Monkey VD ELISA Kit |
|||
| EMKV0030 | Abclonal | 96Tests | EUR 625.2 |
Mouse VD ELISA Kit |
|||
| EMV0030 | Abclonal | 96Tests | EUR 625.2 |
Mouse VD ELISA Kit |
|||
| EMV0033 | Abclonal | 96Tests | EUR 625.2 |
Bovine VD ELISA Kit |
|||
| EBV0030 | Abclonal | 96Tests | EUR 625.2 |
Bovine VD ELISA Kit |
|||
| EBV0033 | Abclonal | 96Tests | EUR 625.2 |
Chicken VD ELISA Kit |
|||
| ECKV0030 | Abclonal | 96Tests | EUR 625.2 |
Anserini VD ELISA Kit |
|||
| EAV0030 | Abclonal | 96Tests | EUR 625.2 |
Anserini VD ELISA Kit |
|||
| EAV0033 | Abclonal | 96Tests | EUR 625.2 |
Canine VD ELISA Kit |
|||
| ECV0030 | Abclonal | 96Tests | EUR 625.2 |
Canine VD ELISA Kit |
|||
| ECV0033 | Abclonal | 96Tests | EUR 625.2 |
Sheep VD ELISA Kit |
|||
| ESV0030 | Abclonal | 96Tests | EUR 625.2 |
Horse Vitamin D(VD) |
|||
| QY-E120083 | Qayee Biotechnology | 96T | EUR 573.6 |
Ivacaftor hydrate |
|||
| A3511-10 | ApexBio | 10 mg | EUR 320.4 |
|
Description: Description:IC50 Value: 25 nM (F508del-CFTR);100 nM (G551D-CFTR) [1]Ivacaftor (VX-770) is a CFTR Potentiator approved for patients with the G551D mutation of cystic fibrosis, which accounts for 4-5% cases of cystic fibrosis. |
|||
Ivacaftor hydrate |
|||
| A3511-100 | ApexBio | 100 mg | EUR 1470 |
|
Description: Description:IC50 Value: 25 nM (F508del-CFTR);100 nM (G551D-CFTR) [1]Ivacaftor (VX-770) is a CFTR Potentiator approved for patients with the G551D mutation of cystic fibrosis, which accounts for 4-5% cases of cystic fibrosis. |
|||
Ivacaftor hydrate |
|||
| A3511-5 | ApexBio | 5 mg | EUR 211.2 |
|
Description: Description:IC50 Value: 25 nM (F508del-CFTR);100 nM (G551D-CFTR) [1]Ivacaftor (VX-770) is a CFTR Potentiator approved for patients with the G551D mutation of cystic fibrosis, which accounts for 4-5% cases of cystic fibrosis. |
|||
Ivacaftor hydrate |
|||
| A3511-50 | ApexBio | 50 mg | EUR 1036.8 |
|
Description: Description:IC50 Value: 25 nM (F508del-CFTR);100 nM (G551D-CFTR) [1]Ivacaftor (VX-770) is a CFTR Potentiator approved for patients with the G551D mutation of cystic fibrosis, which accounts for 4-5% cases of cystic fibrosis. |
|||
CHAPS Hydrate |
|||
| 20-abx082319 | Abbexa |
|
|
Entecavir Hydrate |
|||
| A1767-100 | ApexBio | 100 mg | EUR 1284 |
|
Description: Entecavir hydrate is a reverse transcriptase inhibitor.Reverse transcriptase (RT) is used to generate complementary DNA (cDNA) from an RNA template, which is mainly associated with retroviruses, such as HBV. |
|||
Entecavir Hydrate |
|||
| A1767-25 | ApexBio | 25 mg | EUR 448.8 |
|
Description: Entecavir hydrate is a reverse transcriptase inhibitor.Reverse transcriptase (RT) is used to generate complementary DNA (cDNA) from an RNA template, which is mainly associated with retroviruses, such as HBV. |
|||
Entecavir Hydrate |
|||
| A1767-5 | ApexBio | 5 mg | EUR 170.4 |
|
Description: Entecavir hydrate is a reverse transcriptase inhibitor.Reverse transcriptase (RT) is used to generate complementary DNA (cDNA) from an RNA template, which is mainly associated with retroviruses, such as HBV. |
|||